NASDAQ:SNNA Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis → Do NOT read if you believe in “woke” politics (From Stansberry Research) (Ad) Free SNNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.11▼$0.1750-Day Range$0.14▼$0.1452-Week Range$0.06▼$3.80Volume13.32 million shsAverage Volume1.87 million shsMarket Capitalization$4.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sienna Biopharmaceuticals alerts: Email Address Ad Wealth Builders InstituteNo experience to confident trader, meet my student…Uncover the secrets to stress-free trading and discover how you can start seeing profits without the steep learning curve.Click here About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Read More Ad Wealth Builders InstituteNo experience to confident trader, meet my student…Uncover the secrets to stress-free trading and discover how you can start seeing profits without the steep learning curve.Click here SNNA Stock News HeadlinesMay 6, 2024 | msn.comSienna Miller Brings Back Boho At The Met Gala 2024May 6, 2024 | msn.comSienna Miller Gives Boho Bridal Vibes as She Joins the Chloé Cool Girls on Met Gala 2024 Red CarpetMay 6, 2024 | Stansberry Research (Ad)Do NOT read if you believe in “woke” politicsI have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.May 6, 2024 | msn.comNew mum Sienna Miller steps out in green mini dress in NYC ahead of the Met GalaMay 6, 2024 | msn.comPolice search for Sienna, 15, last seen three days agoMay 3, 2024 | msn.comWhy Kevin Costner Is Taking Sienna Miller and His Female “Horizon” Costars with Him to Cannes (Exclusive)May 3, 2024 | msn.comWho is Lady Lola Bute, who just threw a Saltburn-like party? The 25-year-old aristocrat daughter of an F1 driver celebrated her birthday with Sienna Miller, Charlotte Tilbury ...May 3, 2024 | msn.comSienna Miller nails transitional dressing in afforable trenchMay 6, 2024 | Stansberry Research (Ad)Do NOT read if you believe in “woke” politicsI have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.May 3, 2024 | msn.comSienna Sauce boss Tyla-Simone Crayton makes her dream a realityMay 2, 2024 | nz.news.yahoo.comWhy Kevin Costner Is Only Taking Sienna Miller and His Female “Horizon” Costars with Him to Cannes (Exclusive)April 30, 2024 | msn.comMutfwang unveils 20 Sienna buses for inter-city transportation businessApril 29, 2024 | msn.comPrincess Beatrice's daughter Sienna taking after Princess Charlotte with favourite hobbyApril 27, 2024 | msn.comSienna Miller's affordable gold earrings are back in stock - snap them up before they sell out againApril 26, 2024 | uk.style.yahoo.comSienna Miller's sell-out earrings are finally back in stockApril 26, 2024 | msn.comSienna Miller's sell-out Missoma stud earrings are finally back in stockApril 16, 2024 | msn.comSienna Miller’s wedding and baby number three joyApril 12, 2024 | msn.comSienna Wildgust, NHRA Pro Stock's Youngest Female Racer Is 'Breath of Fresh Air'April 9, 2024 | msn.comHollyoaks airs gunshot twist in Sienna Blake storyApril 9, 2024 | msn.comSienna Mapelli Mozzi ‘looks exactly’ like mom Princess BeatriceApril 9, 2024 | msn.comRevealed: Who Princess Beatrice's rarely seen daughter Sienna looks likeApril 8, 2024 | msn.comPrincess Beatrice 'a fantastic mum' to daughter Sienna, stepmum to WolfieApril 6, 2024 | msn.comHollyoaks star Anna Passey fears potential end of Sienna and Ste's friendshipApril 2, 2024 | uk.news.yahoo.comHollyoaks confirms hostage drama for Sienna as Warren plan backfiresApril 2, 2024 | msn.comHollyoaks spoiler: Sienna records Warren's confessionApril 2, 2024 | msn.comMorgan Coleman, Sienna Chirieleison, Alexis Kuntz lead Trinity lacrosse past NorthernApril 1, 2024 | msn.comHollyoaks confirms terrifying home invasion as Sienna Blake is held at gunpointSee More Headlines Receive SNNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2019Today5/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNNA CUSIPN/A CIK1656328 Webwww.siennabio.com Phone(818) 629-2256FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-177.36% Return on Assets-52.22% Debt Debt-to-Equity RatioN/A Current Ratio15.27 Quick Ratio15.27 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.11Miscellaneous Outstanding Shares30,908,000Free FloatN/AMarket Cap$4.20 million OptionableNot Optionable Beta2.67 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesFrederick C. BeddingfieldPresident, Chief Executive Officer & DirectorMajed KheirVice President-OperationsPaul F. LizzulChief Medical OfficerSilvio TraversaChief Scientific OfficerTodd J. HarrisDirector & Head-Corporate DevelopmentKey CompetitorsGT BiopharmaNASDAQ:GTBPTharimmuneNASDAQ:THARLongeveronNASDAQ:LGVNGenprexNASDAQ:GNPXEnsysce BiosciencesNASDAQ:ENSCView All Competitors SNNA Stock Analysis - Frequently Asked Questions How were Sienna Biopharmaceuticals' earnings last quarter? Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) posted its earnings results on Thursday, March, 14th. The company reported ($0.93) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.83) by $0.10. What other stocks do shareholders of Sienna Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC). When did Sienna Biopharmaceuticals IPO? Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets acted as the underwriters for the IPO. This page (NASDAQ:SNNA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press2024 Oil BoomThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sienna Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.